Clinical Trial: Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT06968546) titled 'Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.' on April 24.

Brief Summary: This study aims to compare two treatments for managing severe pain in children who have suffered trauma and are treated in pediatric emergency departments. Specifically, it evaluates intranasal sufentanil (the experimental treatment) versus intranasal ketamine (the reference treatment). The study hypothesizes that sufentanil will be non-inferior to ketamine in terms of pain relief, with a goal of reducing the pain score by at least two points on the visual analog scale (VAS) which ranges from 0 to 10...